
Operating Companies · Portfolio Valuation
Private Equity · Patent Diligence
Driven before the deal closed - diligence that paid for itself many times over at the negotiating table.
White-space filings, candidate trade secrets protected, and the portfolio positioned for the eventual exit.
A PE firm was preparing to acquire a middle-market company in a crowded specialty services space. The target's pitch leaned hard on its global patent portfolio - but the space had several significant competitors, and nobody on the deal team could say whether that portfolio was a genuine moat, a pile of expensive paper, or a hidden liability.
Get it wrong in one direction, and you overpay for protection that isn't there. Get it wrong in the other, and you walk away from a mispriced asset. Either mistake costs more than the diligence ever would.
We evaluated every patent on the indicia that actually predict value - claim scope, detectability, file history, specification strength - and segmented the portfolio by technology to show exactly what the company had exclusive rights to, and what it didn't.
Using patent data, internal metrics, and our analysis software, we built a taxonomy of the relevant patent space and assessed the portfolios of competitors, customers, and suppliers - flagging third-party patents that posed infringement risk, blocked expansion, or signaled disruptive technology on the horizon.
After the close, the same landscape became the portfolio company's IP roadmap: white space for strategic filings, recommendations for future development, and candidate trade secrets worth protecting.
Same question, different portfolio? Thirty minutes is enough to find out.
Book a CallThe firm walked into final negotiations knowing precisely what the portfolio was worth - and what it wasn't. The analysis drove a meaningful price adjustment before the deal closed - diligence that paid for itself many times over at the negotiating table.
Post-close, the same work product became the portfolio company's go-forward IP strategy: a roadmap for filing into identified white space, protecting candidate trade secrets, and positioning the portfolio as a value driver for the eventual exit.
The Cost Of Waiting
Every deal that closes without real patent diligence prices the portfolio at zero - or worse, at whatever the seller claims. Thirty minutes is enough to tell you whether the IP in your next deal deserves a closer look.
More Case Studies

Operating Companies · Portfolio Valuation

Investors & Lenders · Portfolio Assessment

Operating Companies · Patent Mining

Operating Companies · Independent Assessment

Operating Companies · Litigation Finance